Pages that link to "Q36619185"
Jump to navigation
Jump to search
The following pages link to Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer (Q36619185):
Displaying 16 items.
- Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (Q33343743) (← links)
- Perspectives in cancer chemotherapy (Q34402152) (← links)
- Radiosensitization with chemotherapeutic agents. (Q34462596) (← links)
- Locally advanced non-small cell lung cancer (Q34678456) (← links)
- Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors (Q35051964) (← links)
- Basic treatment considerations: chemotherapy. (Q35684081) (← links)
- Radiation and third-generation chemotherapy (Q35684088) (← links)
- DNA topoisomerase I drugs and radiotherapy for lung cancer (Q36186315) (← links)
- Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial (Q36611661) (← links)
- Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer (Q37091425) (← links)
- Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective (Q38133562) (← links)
- Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer (Q43660233) (← links)
- Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer. (Q44176815) (← links)
- Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study. (Q44520757) (← links)
- Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study. (Q53545676) (← links)
- Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group (Q92588670) (← links)